Trial Profile
Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2020
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 08 Jun 2018 New trial record